Revive Therapeutics – Studying Bucillamine to Treat COVID
Michael Frank, CEO and Chairman of Revive Therapeutics discusses the Phase 3 trial of Bucillamine, a well known prescribed anti-inflammatory drug in Japan and South Korea, as an oral at-home pill treatment option for mild-moderate to severe COVID-19.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on COVID. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in COVID and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about COVID?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Michael Frank, CEO and Chairman of Revive
Stepped in as CEO in 2019 and took Revive’s market cap from just $1.4 million to over $100M
Strong background in operations, business development, M&A, the capital markets and has been instrumental in advising several early stage software companies including a number in the cannabis sector over the last few years
Currently the President of Mifran Consulting, providing advisory services to emerging technology companies in a number of key verticals.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
